FlawCheck Citator
Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10386196
United States Court of Appeals for the Ninth Circuit

Allen v. Dudek

No. 10386196 · Decided April 28, 2025
No. 10386196 · Ninth Circuit · 2025 · FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
April 28, 2025
Citation
No. 10386196
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 28 2025 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT SUSAN E. ALLEN, No. 24-2927 D.C. No. Plaintiff - Appellant, 2:22-cv-02154-JAT v. MEMORANDUM* LELAND DUDEK, Acting Commissioner of Social Security, Defendant - Appellee. Appeal from the United States District Court for the District of Arizona James A. Teilborg, District Judge, Presiding Argued and Submitted April 8, 2025 San Francisco, California Before: SCHROEDER, PAEZ, and MILLER, Circuit Judges. Susan Allen appeals the district court’s order affirming the Commissioner of Social Security’s denial of her application for disability benefits under the Social Security Act. We have jurisdiction under 28 U.S.C. § 1291. We review the agency’s legal conclusions de novo and its factual findings for substantial * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. evidence. See Ford v. Saul, 950 F.3d 1141, 1153–54 (9th Cir. 2020). We reverse the judgment of the district court and remand with instructions to remand to the Commissioner of Social Security for further proceedings. The administrative law judge (ALJ) found that Allen had the residual functional capacity to perform light work, despite Allen’s claim that her fibromyalgia, among other conditions, caused too much pain to allow her to engage in that level of activity. Fibromyalgia is a “rheumatic disease that causes inflammation of the fibrous connective tissue components of muscles, tendons, ligaments, and other tissue,” and typical symptoms include global chronic pain, fatigue, and stiffness. Revels v. Berryhill, 874 F.3d 648, 656 (9th Cir. 2017) (quoting Benecke v. Barnhart, 379 F.3d 587, 589 (9th Cir. 2004)). It is an “unusual” disease in that “those suffering from it have ‘muscle strength, sensory functions, and reflexes [that] are normal.’” Id. (alteration in original) (quoting Rollins v. Massanari, 261 F.3d 853, 863 (9th Cir. 2001) (Ferguson, J., dissenting)). “In evaluating whether a claimant’s residual functional capacity renders [the claimant] disabled because of fibromyalgia, the medical evidence must be construed in light of fibromyalgia’s unique symptoms and diagnostic methods,” including that “[t]he condition is diagnosed ‘entirely on the basis of patients’ reports of pain and other symptoms.’” Id. at 662, 666 (quoting Benecke, 379 F.3d at 590). 2 24-2927 The ALJ rejected Allen’s testimony about the severity of her symptoms on the ground that her testimony was inconsistent with the medical evidence. The ALJ gave four reasons for rejecting Allen’s testimony, but none is supported by substantial evidence. First, the ALJ found that Allen “has not generally received the type of medical treatment one would expect for a totally disabled individual.” Allen, however, has received several forms of intensive treatment for her pain, including the maximum dose of narcotic medication. Second, the ALJ found that Allen’s “medications have been relatively effective in controlling” her symptoms. While the evidence shows that her medication regimen has reduced her pain to some degree, the evidence does not show that it reduced her pain to a level low enough to be inconsistent with her symptom testimony. Third, the ALJ found that Allen’s “examinations demonstrate greater functioning than” she described because they “generally showed normal gait and posture,” as well as normal reflexes and no muscle weakness or atrophy. But “normal muscle strength, tone, and stability, as well as a normal range of motion,” are all “perfectly consistent with debilitating fibromyalgia.” Revels, 874 F.3d at 666. Fourth, the ALJ found that Allen’s “many reportedly intact activities of daily living” were inconsistent with the limitations to which she testified. The evidence, however, reflects that Allen’s activities were significantly limited by her pain. For example, although Allen was able to cook quick meals and do certain cleaning tasks, her daughters 3 24-2927 and husband often cooked and cleaned for her because of her pain levels. Thus, substantial evidence does not support the ALJ’s rejection of Allen’s testimony based on those purported inconsistencies. In addition, the ALJ afforded no weight to the opinion of Allen’s treating physician. See Revels, 874 F.3d at 654 (holding that the medical opinion of a claimant’s treating doctor is ordinarily given “controlling weight” (quoting 20 C.F.R. § 404.1527(c)(2))). None of the reasons the ALJ gave for doing so is supported by substantial evidence. The ALJ found that the physician’s opinion was “inconsistent with the evidence showing that” Allen’s “medication helped to relieve pain” and that Allen had “normal gait, sensation, and reflexes.” Those were insufficient bases to reject the physician’s opinion for the same reasons they were insufficient to reject Allen’s testimony. The ALJ also discounted the physician’s opinion because it was based on Allen’s “subjective reports of pain.” But because a claimant’s subjective reports of pain form the basis for diagnosing fibromyalgia, they can also properly form the basis for assessing the limitations of a claimant who suffers from the disease. See id. at 663, 665–66. REVERSED and REMANDED. 4 24-2927
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 28 2025 MOLLY C.
Key Points
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS APR 28 2025 MOLLY C.
FlawCheck shows no negative treatment for Allen v. Dudek in the current circuit citation data.
This case was decided on April 28, 2025.
Use the citation No. 10386196 and verify it against the official reporter before filing.
Why Attorneys Choose FlawFinder

Why Attorneys Choose FlawFinder

Side-by-side with Westlaw and LexisNexis

Feature FlawFinder Westlaw LexisNexis
Monthly price$19 – $99$133 – $646$153 – $399
ContractNone1–3 year min1–6 year min
Hidden fees$0, alwaysUp to $469/search$25/mo + per-doc
FlawCheck citatorIncludedKeyCite ($$$)Shepard's ($$$)
Plain-English summaryIncludedNoNo
CancelOne clickTermination feesAccount friction
Related Cases

Full legal research for $19/month

All 50 states · Federal regulations · Case law · Police SOPs · AI analysis included · No contract

Continue Researching →